姓名:徐慧萍醫師

主要學歷

現職

經歷

專長

學術成大

學術論文

1.      Hui-Ping Hsu, Chih-Yang Wang, Pei-Yin Hsieh, Jung-Hua Fang, Yi-Ling Chen*. Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model. J Cancer 2020; 11(1): 213-228. (SCI)

2.      Chih-Yang Wang, Yung-Chieh Chang, Yao-Lung Kuo, Kuo-Ting Lee, Pai-Sheng Chen, Chun Hei Antonio Cheung, Chih-Peng Chang, Nam Nhut Phan, Meng-Ru Shen, Hui-Ping Hsu*. Mutation of the PTCH1 gene predicts recurrence of breast cancer. Sci Rep 2019 9(1): 16359. (SCI, Corresponding author)

3.      Chia-Yi Su, Ruei-Liang Yan, Wen-Hsin Hsu, Ching-Tung Chu, Hsuan-Chia Chang, Chien-Chen Lai, Hui-Ping Hsu, Hong-Chen Chen. Phosphorylation of adducin-1 by cyclin-dependent kinase 5 is important for epidermal growth factor-induced cell migration. Sci Rep 2019; 9(1): 13703.e1-13703.e11. (SCI)

4.      Wei-Pang Chung, Ya-Tin Hsu, Ya-Ping Chen, Hui-Ping Hsu*. Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: a case report. Medicine (Baltimore) 2019; 98(13): e14987.1-e14987.3. (SCI, Corresponding author)

5.      Tsung-Han Yang, Jen-Lung Chen, Yih-Jyh Lin, Ying-Jui Chao, Yan-Shen Shan, Hui-Ping Hsu, Zhe-Min Su, Chung-Ching Chou, Yi-Ting Yen*. Laparoscopic surgery for large left lateral liver tumors: safety and oncologic outcomes. Surg Endosc 2018; 32(10): 4314-4320. (SCI)

6.      Tzu-Yang Weng, Hsuan Franziska Wu, Chung-Yen Li, Yu-Hsuan Hung, Yu-Wei Chang, Yi-Ling Chen, Hui-Ping Hsu, Yu-Hung Chen, Chih-Yang Wang, Jang-Yang Chang, Ming-Derg Lai*. Homoharringtonine induced immune alteration for an efficient anti-tumor response in mouse models of non-small cell lung adenocarcinoma expressing Kras Mutation. Sci Rep 2018; 8(1): 8216. (SCI)

7.      Tzu-Yang Weng, Chia-Jung Li, Chung-Yen Li, Yu-Hsuan Hung, Meng-Chi Yen, Yu-Wei Chang, Yu-Hung Chen, Yi-Ling Chen, Hui-Ping Hsu, Jang-Yang Chang, Ming-Derg Lai*. Skin delivery of Clec4a small hairpin RNA elicited an effective antitumor response by enhancing CD8⁺ immunity in vivo. Mol Ther Nucleic Acids. 2017; 9: 419-427. (SCI)

8.      Chih-Yang Wang, Chung-Yen Li, Hui-Ping Hsu, Chien-Yu Cho, Meng-Chi Yen, Tzu-Yang Weng, Wei-Ching Chen, Yu-Hsuan Hung, Kuo-Ting Lee, Jui-Hsiang Hung, Yi-Ling Chen, Ming-Derg Lai*. PSMB5 plays a dual role in cancer development and immunosuppression. Am J Cancer Res 2017; 7(11): 2103-2120. (SCI)

9.      Yan-Shen Shan, Hui-Ping Hsu, Ming-Derg Lai, Yu-Hsuan Hung, Chih-Yang Wang, Meng-Chi Yen, Yi-Ling Chen*. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer. Oncol Lett 2017; 14(4): 4517-4526. (SCI, Co-first author)

10.  Hui-Ping Hsu, Ming-Derg Lai, Jenq-Chang Lee, Meng-Chi Yen, Tzu-Yang Weng, Wei-Ching Chen, Jung-Hua Fang, Yi-Ling Chen*. Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling. Sci Rep 2017; 7(1): 5823. (SCI)

11.  Zhu-Jun Loh, Kuo-Ting Lee, Wei-Pang Chung, Wen-Chung Chen, Hsueh-Li Kuo, Po-Jun Chen, Hsi-Huei Lu, Hui-Ping Hsu*. Invasive lobular carcinoma of the breast with synchronous colon metastasis. Formosan J Surg 2017 Apr; 50(2): 69-73. (Corresponding author)

12.  Hau-Lun Huang, Wei-Ching Chen, Hui-Ping Hsu, Chien-Yu Cho, Yu-Hsuan Hung, Chih-Yang Wang, Ming-Derg Lai*. Silencing of argininosuccinate lyase inhibits colorectal cancer formation. Oncol Rep 2017; 37(1): 163-170. (SCI)

13.  Ming-Jenn Chen, Yi-Ling Chen, Tzu-Wen Wang, Hui-Ping Hsu*, Ming-Derg Lai. The membrane bile acid receptor TGR5 predicts good prognosis in ampullary adenocarcinoma patients with hyperbilirubinemia. Oncol Rep 2016; 36: 1997-2008. (SCI, Corresponding author)

14.  Wei-Ching Chen, Hui-Ping Hsu, Chung-Yen Li, Ya-Ju Yang, Yu-Hsuan Hung, Chien-Yu Cho, Chih-Yang Wang, Tzu-Yang Weng, Ming-Derg Lai*. Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin. Int J Oncol 2016; 49(5): 1881-1889. (SCI)

15.  Chih-Ming Su, Ting-Yu Chang, Hui-Ping Hsu, Hui-Huang Lai, Jie-Ning Li, Yu-Jhen Lyu, Kuang-Tai Kuo, Ming-Te Huang, Jen-Liang Su, Pai-Sheng Chen. A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer. Oncotarget 2016; 7(39): 63924-63936. (SCI)

16.  Chien-Yu Cho, Kuo-Ting Lee, Wei-Ching Chen, Chih-Yang Wang, Yung-Sheng Chang, Hau-Lun Huang, Hui-Ping Hsu, Meng-Chi Yen, Ming-Zong Lai, Ming-Derg Lai*. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer. Oncotarget 2016; 7(6): 7542.e1-e19. (SCI)